Quick Answer
CV Sciences, Inc. reported Diluted EPS of $0.01 per share (loss) for fiscal year 2025.
CV Sciences, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.01 | +0.0% |
| 2024 | -$0.01 | -150.0% |
| 2023 | $0.02 | +128.6% |
| 2022 | -$0.07 | +50.0% |
| 2021 | -$0.14 | +36.4% |
| 2020 | -$0.22 | -29.4% |
| 2019 | -$0.17 | -288.9% |
| 2018 | $0.09 | +250.0% |
| 2017 | -$0.06 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | +100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | — |
| September 30, 2023 | $0.00 | +100.0% | +100.0% |
| June 30, 2023 | -$0.01 | +66.7% | -125.0% |
- CV Sciences, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2017–2025 period, CV Sciences, Inc.’s diluted eps has grown by 83.3% (from $0.06 per share (loss) to $0.01 per share (loss)).
- The most recent figure is from CV Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: